Active Ingredient: NAPHAZOLINE HYDROCHLORIDE
Proprietary Name: VASOCON
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 0.1%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A080235
Product Number: 002
Approval Date: Mar 24, 1983
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information
